Director Somers John A. acquired 2,000 shares in Colony Capital, Inc. (NYSE:CLNY) for $45,960 in transaction occurred on 2018/03/23. After making this transaction, the Director owns a direct stake of 11,320 shares, worth $282,654, as per the last closing price. On 2018/03/06 Steffens John, Director at CLNY, purchased 10,000 shares at an average price of $5.94 per share. The new stake is valued at $379,394.
Separately, it had been reported that some other CLNY insiders also took part of the insider trading activity. Director, Schoenherr Charles W had invested in 16,000 shares for $46,604 through a trade on 2018/03/06. Following this activity, the insider holds 94,080 shares worth $286,615 as of recent close. Wall Street’s most bullish Colony Capital, Inc. (NYSE:CLNY) analysts are predicting the share price to blow past $10 per share during the next 12 months. The current median share price forecast by them is $9, suggesting that the stock could increase 46.34% in that time frame. The average price target of $8.5 calls for a nearly 38.21% increase in the stock price.
Colony Capital, Inc. (CLNY) trading activity significantly improved as the volume at ready counter increased to 3,280,384 shares versus 2,888,630 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 5,647,158 shares. The share price rose 1.82% in recent trade and currently has a stock-market value of $2.95B. The shares finished at $6.15, after trading as low as $5.92 earlier in the session. It hit an intraday high Thursday at $6.15. The stock is now 16.48% above against its bear-market low of $5.28 on March 01, 2018. It has retreated -100.16% since it’s 52-week high of $12.31 reached in December. Now the market price is down -49.26% on the year and down -46.1% YTD.
CLNY’s 50 day simple moving average (SMA 50) price is $5.91 and its 200-day simple moving average (SMA 200) price is $6.04. The company’s stock currently has a total float of 478.85M shares. Its weekly volatility is hovering around 3.15% and felt 2.58% volatility in price over a month. On the upside, the share price will test short term resistance at around $6.23. On a downside, the stock is likely to find some support, which begins at $6. The failure to get near-term support could push it to $5.84.
Also, it is trading at rather inexpensive levels at just over 0.49x price/book and 1.07x price/sales. Compared to others, Colony Capital, Inc. is in a different league with regards to profitability, having net margins of -22.1%. To put some perspective around this, the industry’s average net margin is 153.43%. CLNY’s ROE is -9.5%, which is also considerably worse than the industry’s ROE of 12.77%.
Shares of Colony Capital, Inc. (CLNY) have gained 4.5% since the company’s last earnings report. Over the past 12 fiscal quarters, Colony Capital, Inc. (NYSE:CLNY) has topped consensus earnings estimates in 1 quarters (8%), missed earnings in 10 quarters (83%), whereas at 1 occasion EPS met analyst expectations. Revenue for the recent quarter stood at $59.99 million, down -44% on last year and above the $41.4 million predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $39.3 million to $55.3 million, which should be compared with $114.29 million generated last year. EPS is seen in a range of -$2.80E-01 to -$0.1, against the $0.07 reported a year ago.